LataMed AI is trading 12.5% down at $0.07, with no clear company-specific announcement explaining the September 28 decline. - Its latest identified company news was a September 9 cooperation agreement, which does not establish a reason for the decline. - Broader markets were under pressure as oil rose amid stalled U.S.-Iran talks and Treasury yields climbed on expectations for higher rates. - These conditions may have added to negative sentiment, but available evidence does not confirm they directly caused LataMed AI’s decline.